Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0001 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |